Evolent Health Statistics Share Statistics Evolent Health has 115.97M
shares outstanding. The number of shares has increased by -0.51%
in one year.
Shares Outstanding 115.97M Shares Change (YoY) -0.51% Shares Change (QoQ) -1.22% Owned by Institutions (%) 96.45% Shares Floating 114.24M Failed to Deliver (FTD) Shares 186,618 FTD / Avg. Volume 5.9%
Short Selling Information The latest short interest is 23.1M, so 19.92% of the outstanding
shares have been sold short.
Short Interest 23.1M Short % of Shares Out 19.92% Short % of Float 20.16% Short Ratio (days to cover) 11.19
Valuation Ratios The PE ratio is -20.94 and the forward
PE ratio is 13.16.
Evolent Health's PEG ratio is
0.57.
PE Ratio -20.94 Forward PE 13.16 PS Ratio 0.51 Forward PS 0.4 PB Ratio 1.29 P/FCF Ratio -210.54 PEG Ratio 0.57
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Evolent Health.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.85,
with a Debt / Equity ratio of 0.71.
Current Ratio 0.85 Quick Ratio 0.85 Debt / Equity 0.71 Debt / EBITDA 8.41 Debt / FCF -116.46 Interest Coverage -1.64
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $567.72K Profits Per Employee $-13.69K Employee Count 4,500 Asset Turnover 1 Inventory Turnover n/a
Taxes Income Tax -1.41M Effective Tax Rate 2.24%
Stock Price Statistics The stock price has increased by -68.83% in the
last 52 weeks. The beta is 0.66, so Evolent Health's
price volatility has been higher than the market average.
Beta 0.66 52-Week Price Change -68.83% 50-Day Moving Average 9.18 200-Day Moving Average 9.72 Relative Strength Index (RSI) 42.13 Average Volume (20 Days) 3,163,430
Income Statement In the last 12 months, Evolent Health had revenue of 2.55B
and earned -61.62M
in profits. Earnings per share was -0.81.
Revenue 2.55B Gross Profit 367.35M Operating Income -40.48M Net Income -61.62M EBITDA 84.85M EBIT -38.31M Earnings Per Share (EPS) -0.81
Full Income Statement Balance Sheet The company has 104.2M in cash and 713.67M in
debt, giving a net cash position of -609.47M.
Cash & Cash Equivalents 104.2M Total Debt 713.67M Net Cash -609.47M Retained Earnings -780.82M Total Assets 2.46B Working Capital 4.74M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 18.77M
and capital expenditures -24.89M, giving a free cash flow of -6.13M.
Operating Cash Flow 18.77M Capital Expenditures -24.89M Free Cash Flow -6.13M FCF Per Share -0.05
Full Cash Flow Statement Margins Gross margin is 14.38%, with operating and profit margins of -1.58% and -2.41%.
Gross Margin 14.38% Operating Margin -1.58% Pretax Margin -2.47% Profit Margin -2.41% EBITDA Margin 3.32% EBIT Margin -1.58% FCF Margin -0.24%
